4911 Stock Overview
A biopharmaceutical company, focuses on the development and commercialization of novel botanical extraction technology and products. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for 4911 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
G&E Herbal Biotechnology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$57.00 |
| 52 Week High | NT$61.70 |
| 52 Week Low | NT$48.58 |
| Beta | -0.17 |
| 1 Month Change | 3.45% |
| 3 Month Change | 6.74% |
| 1 Year Change | 4.53% |
| 3 Year Change | 117.34% |
| 5 Year Change | 65.08% |
| Change since IPO | 13.23% |
Recent News & Updates
Shareholder Returns
| 4911 | TW Personal Products | TW Market | |
|---|---|---|---|
| 7D | -0.7% | -2.3% | -2.1% |
| 1Y | 4.5% | -21.1% | 25.6% |
Return vs Industry: 4911 exceeded the TW Personal Products industry which returned -21.1% over the past year.
Return vs Market: 4911 underperformed the TW Market which returned 25.6% over the past year.
Price Volatility
| 4911 volatility | |
|---|---|
| 4911 Average Weekly Movement | 3.8% |
| Personal Products Industry Average Movement | 4.2% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in TW Market | 7.8% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 4911 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 4911's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 37 | Kou-Wha Kou | www.geherbs.com.tw |
G&E Herbal Biotechnology Co., Ltd., a biopharmaceutical company, focuses on the development and commercialization of novel botanical extraction technology and products. It offers botanical anti-aging cosmetic products, such as facial foam cleanser and cleansing essence, botanical extract toner, lightening lotion, essential oil, and moisturizing serum and cream; SR-100 botanical essence and bromelain illuminating cleansing mousse; and hepato protective agent capsules. The company also provides botanical healthcare products comprising ArthrEnergy, Jujubes Polysaccharide, Diabecut, HepatoClean, Astragali Radix, Goji, Prosta, and SR-100 capsules; and adult products.
G&E Herbal Biotechnology Co., Ltd. Fundamentals Summary
| 4911 fundamental statistics | |
|---|---|
| Market cap | NT$3.36b |
| Earnings (TTM) | NT$83.82m |
| Revenue (TTM) | NT$211.15m |
40.1x
P/E Ratio15.9x
P/S RatioIs 4911 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4911 income statement (TTM) | |
|---|---|
| Revenue | NT$211.15m |
| Cost of Revenue | NT$40.41m |
| Gross Profit | NT$170.74m |
| Other Expenses | NT$86.91m |
| Earnings | NT$83.82m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.42 |
| Gross Margin | 80.86% |
| Net Profit Margin | 39.70% |
| Debt/Equity Ratio | 0% |
How did 4911 perform over the long term?
See historical performance and comparisonDividends
0.9%
Current Dividend Yield38%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 02:45 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
G&E Herbal Biotechnology Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Regina Lee | Jih Sun Securities Investment Consulting Co., Ltd. |
| Evana Chen | Masterlink Securities Corp. |